107 related articles for article (PubMed ID: 27011383)
21. Potential role of organic anion transporting polypeptide 1B1 (OATP1B1) in the selective hepatic uptake of hematoporphyrin monomethyl ether isomers.
Li XL; Guo ZT; Wang YD; Chen XY; Liu J; Zhong DF
Acta Pharmacol Sin; 2015 Feb; 36(2):268-80. PubMed ID: 25418376
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of expression of hepatic organic anion-transporting polypeptide (OATP) transporters in cellular systems relative to human liver tissue.
Badée J; Achour B; Rostami-Hodjegan A; Galetin A
Drug Metab Dispos; 2015 Apr; 43(4):424-32. PubMed ID: 25564656
[TBL] [Abstract][Full Text] [Related]
23. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
Kindla J; Müller F; Mieth M; Fromm MF; König J
Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
[TBL] [Abstract][Full Text] [Related]
24. Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury.
Li X; Zhong K; Guo Z; Zhong D; Chen X
Drug Metab Dispos; 2015 Nov; 43(11):1751-9. PubMed ID: 26276582
[TBL] [Abstract][Full Text] [Related]
25. Comparing myotoxic effects of squalene synthase inhibitor, T-91485, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in human myocytes.
Nishimoto T; Tozawa R; Amano Y; Wada T; Imura Y; Sugiyama Y
Biochem Pharmacol; 2003 Dec; 66(11):2133-9. PubMed ID: 14609738
[TBL] [Abstract][Full Text] [Related]
26. The peptide-based thrombin inhibitor CRC 220 is a new substrate of the basolateral rat liver organic anion-transporting polypeptide.
Eckhardt U; Horz JA; Petzinger E; Stüber W; Reers M; Dickneite G; Daniel H; Wagener M; Hagenbuch B; Stieger B; Meier PJ
Hepatology; 1996 Aug; 24(2):380-4. PubMed ID: 8690408
[TBL] [Abstract][Full Text] [Related]
27. Expression and transport function of drug uptake transporters in differentiated HepaRG cells.
Kotani N; Maeda K; Debori Y; Camus S; Li R; Chesne C; Sugiyama Y
Mol Pharm; 2012 Dec; 9(12):3434-41. PubMed ID: 22897388
[TBL] [Abstract][Full Text] [Related]
28. Characterization of digoxin uptake in sandwich-cultured human hepatocytes.
Kimoto E; Chupka J; Xiao Y; Bi YA; Duignan DB
Drug Metab Dispos; 2011 Jan; 39(1):47-53. PubMed ID: 20926619
[TBL] [Abstract][Full Text] [Related]
29. Long-lasting inhibition of the transporter-mediated hepatic uptake of sulfobromophthalein by cyclosporin a in rats.
Shitara Y; Nagamatsu Y; Wada S; Sugiyama Y; Horie T
Drug Metab Dispos; 2009 Jun; 37(6):1172-8. PubMed ID: 19282398
[TBL] [Abstract][Full Text] [Related]
30. The new acyl-CoA cholesterol acyltransferase inhibitor SMP-797 does not interact with statins via OATP1B1 in human cryopreserved hepatocytes and oocytes expressing systems.
Kitamura A; Imai S; Yabuki M; Komuro S
Biopharm Drug Dispos; 2007 Dec; 28(9):517-25. PubMed ID: 17918775
[TBL] [Abstract][Full Text] [Related]
31. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.
De Bruyn T; Ye ZW; Peeters A; Sahi J; Baes M; Augustijns PF; Annaert PP
Eur J Pharm Sci; 2011 Jul; 43(4):297-307. PubMed ID: 21605667
[TBL] [Abstract][Full Text] [Related]
32. Lapaquistat acetate, a squalene synthase inhibitor, changes macrophage/lipid-rich coronary plaques of hypercholesterolaemic rabbits into fibrous lesions.
Shiomi M; Yamada S; Amano Y; Nishimoto T; Ito T
Br J Pharmacol; 2008 Jul; 154(5):949-57. PubMed ID: 18587443
[TBL] [Abstract][Full Text] [Related]
33. Organic anion-transporting polypeptides contribute to the hepatic uptake of berberine.
Chen C; Wu ZT; Ma LL; Ni X; Lin YF; Wang L; Chen KP; Huang CG; Pan G
Xenobiotica; 2015; 45(12):1138-46. PubMed ID: 26068524
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of hepatic uptake transporters by flavonoids.
Mandery K; Balk B; Bujok K; Schmidt I; Fromm MF; Glaeser H
Eur J Pharm Sci; 2012 May; 46(1-2):79-85. PubMed ID: 22394605
[TBL] [Abstract][Full Text] [Related]
35. Carrier-mediated hepatic uptake of a novel nonrenal excretion type uric acid generation inhibitor, Y-700.
Sai Y; Kato Y; Nakamura K; Kato S; Nishimura T; Kubo Y; Tamai I; Yang S; Hu Z; Yamada I; Tsuji A
J Pharm Sci; 2006 Feb; 95(2):336-47. PubMed ID: 16369928
[TBL] [Abstract][Full Text] [Related]
36. Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.
Durmus S; Lozano-Mena G; van Esch A; Wagenaar E; van Tellingen O; Schinkel AH
Mol Pharm; 2015 Dec; 12(12):4259-69. PubMed ID: 26474710
[TBL] [Abstract][Full Text] [Related]
37. High hepatic exposure of furanocoumarins in Radix Angelica dahuricae is associated with transporter mediated active uptake.
Chen L; Yang H; Yu C; Yuan M; Li H
J Ethnopharmacol; 2018 Feb; 212():74-85. PubMed ID: 29055720
[TBL] [Abstract][Full Text] [Related]
38. Drug evaluation: TAK-475--an oral inhibitor of squalene synthase for hyperlipidemia.
Burnett JR
Curr Opin Investig Drugs; 2006 Sep; 7(9):850-6. PubMed ID: 17002264
[TBL] [Abstract][Full Text] [Related]
39. Lapaquistat acetate: development of a squalene synthase inhibitor for the treatment of hypercholesterolemia.
Stein EA; Bays H; O'Brien D; Pedicano J; Piper E; Spezzi A
Circulation; 2011 May; 123(18):1974-85. PubMed ID: 21518985
[TBL] [Abstract][Full Text] [Related]
40. Characterization of organic anion transporting polypeptide (OATP) expression and its functional contribution to the uptake of substrates in human hepatocytes.
Kimoto E; Yoshida K; Balogh LM; Bi YA; Maeda K; El-Kattan A; Sugiyama Y; Lai Y
Mol Pharm; 2012 Dec; 9(12):3535-42. PubMed ID: 23082789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
